Amyris says “double the revenue” in sight with Nenter Vitamin E Partnership as DSM Vitamin A partnership unveiled

May 11, 2017 |

In California, Amyris said it expects revenue related to its Vitamin E partnership with Nenter to more than double based on the current success of the program. During 2016, the company shipped approximately $9 million of farnesene to Nenter for conversion to Vitamin E and expects 2017 shipments to Nenter to be about $20 million.

The company also announced today that as part of its focus on growing its relationship with DSM, it is entering into an exclusive licensing agreement for Vitamin A within the nutraceuticals market. This relationship is focused on a fast-track to market for the production and commercialization of low-cost supply of Vitamin A.

“Nenter’s investment and commitment to the Vitamin E market has proved to be an ideal partnership for growth by both companies,” said John Melo, Amyris President & CEO. “We are excited by their early commercialization results. This is a great example of combining our technology platform with their capabilities to deliver better chemistry. We plan to replicate this success with DSM on Vitamin A and expect a successful program and delivery of product before the end of 2019.”

Amyris: The Digest’s 2015 5 Minute Guide

Print Friendly, PDF & Email

Tags: ,

Category: Producer News

Thank you for visting the Digest.